ALFA Target Labeling System Evaluation

About NanoTag Biotechnologies

NanoTag Biotechnologies is a private, revenue-generating platform and services company specializing in the discovery, engineering, and production of single-domain antibodies (nanobodies). Its core business model combines a portfolio of validated research reagents (e.g., FluoTags®, Smart Secondaries®, Selector resins) with custom contract research services for sdAb discovery and protein production. The company has secured a significant strategic partnership with BioNTech to evaluate its proprietary ALFA labeling technology across therapeutic areas, indicating a strategic pivot towards therapeutic and diagnostic applications alongside its strong R&D tools business.

Therapeutic Areas